Search

everythinglearnresearchcommunity

for

Search:↓

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

The summit aimed to speed up finding treatments for alopecia areata.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.